1. BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils. Issue 11 (20th April 2017) Authors: Smiljkovic, D.; Blatt, K.; Stefanzl, G.; Dorofeeva, Y.; Skrabs, C.; Focke‐Tejkl, M.; Sperr, W. R.; Jaeger, U.; Valenta, R.; Valent, P. Journal: Allergy Issue: Volume 72:Issue 11(2017:Nov.) Page Start: 1666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. BTK inhibition is a potent approach to block IgE‐mediated histamine release in human basophils. Issue 11 (20th April 2017) Authors: Smiljkovic, D.; Blatt, K.; Stefanzl, G.; Dorofeeva, Y.; Skrabs, C.; Focke‐Tejkl, M.; Sperr, W. R.; Jaeger, U.; Valenta, R.; Valent, P. Journal: Allergy Issue: Volume 72:Issue 11(2017:Nov.) Page Start: 1666 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Isolation of a high‐affinity Bet v 1‐specific IgG‐derived ScFv from a subject vaccinated with hypoallergenic Bet v 1 fragments. Issue 7 (20th February 2018) Authors: Gadermaier, E.; Marth, K.; Lupinek, C.; Campana, R.; Hofer, G.; Blatt, K.; Smiljkovic, D.; Roder, U.; Focke‐Tejkl, M.; Vrtala, S.; Keller, W.; Valent, P.; Valenta, R.; Flicker, S. Journal: Allergy Issue: Volume 73:Issue 7(2018) Page Start: 1425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗